Sandip Raichura of PL Capital Group anticipates near-term market pressure amid global uncertainties, but remains optimistic ...

The company’s strategy for global markets is different from the India market and is not solely based on leveraging ...

Strides Pharma Science share price has rallied 19% in one month and 25% in three months. The small-cap stock is up 10% YTD ...

Despite some recent reversals in trade policy, the broader trend still indicates a rise in trade barriers compared to the ...

Indian Hotels Company, Mazagon Dock Shipbuilders, Max Healthcare Institute, Solar Industries India, Shree Cements, Mankind ...

Shares Biotechnology ETF offers efficient, diversified exposure to the sector's revival, balancing risk and cost for ...

Western drugmakers, investors increasingly aim to acquire Chinese compounds.

Seven pharmaceutical giants with a presence in New Jersey have announced billions in expansions. The timing is no surprise, health care analysts say.

Lilly dominates GLP-1 market but faces near-term headwinds, while AstraZeneca boasts steady growth, rising estimates and a higher dividend yield.

The U.S. stock market has experienced significant volatility recently, with major indices like the Dow Jones and Nasdaq Composite seeing sharp gains following a tech sector rally driven by shifts in ...

Indian markets ended lower Tuesday as the Sensex fell 624 points and Nifty declined 175, dragged by profit booking in ...

The deal tees up a pain treatment market rivalry with Vertex Pharmaceuticals as the industry starts to move away from opioids ...